Abstract
Gastric cancer is an important healthcare problem and represents the second leading cause of death for malignant disease worldwide. In the Western world, the diagnosis is done at late stage when treatments can be only palliative. Searches for new therapeutic regimens as well as for new biomarkers are in progress.
To reduce cancer mortality is crucial the prevention of the lesion at earlier stages. Therefore, new bullets to prevention are needed.
Nowadays, studies relating to different kinds of tumor are unanimous in considering cancer stem cells (CSCs) as “the core” of the tumor and the responsible of tumor chemoresistance and relapse.
This chapter aims to provide the instructions to (1) isolate, (2) grow, and (3) validate, both in vivo and in vitro, the gastric CSC subpopulation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fock KM, Katelaris P, Sugano K et al (2009) Second Asia-Pacific consensus guidelines for helicobacter pylori infection. J Gastroenterol Hepatol 24(10):1587–1600
Leung WK, Sung JJ (2006) Chemoprevention of gastric cancer. Eur J Gastroenterol Hepatol 18(8):867–871
Anderson WF, Camargo MC, Fraumeni JF et al (2010) Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303(17):1723–1728
Ford AC (2011) Chemoprevention for gastric cancer. Best Pract Res Clin Gastroenterol 25(4–5):581–592
Siolas D, Hannon GJ (2013) Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res 73(17):5315–5319
Clarke MF, Dick JE, Dirks PB et al (2006) Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66(19):9339–9344
Mani SA, Guo W, Liao MJ et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715
Takaishi S, Okumura T, Tu S et al (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27(5):1006–1020
Li K, Dan Z, Nie YQ (2014) Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. World J Gastroenterol 20(18):5420–5426
Jiang J, Zhang Y, Chuai S et al (2012) Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Oncogene 31(6):671–682
Han ME, Jeon TY, Hwang SH et al (2011) Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell Mol Life Sci 68(21):3589–3605
Xu G, Shen J, Ou Yang X et al (2013) Cancer stem cells: the ‘heartbeat’ of gastric cancer. J Gastroenterol 48(7):781–797
Gires O, Klein CA, Baeuerle PA (2009) On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer 9(2):143
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Mori, F., Canu, V., Lorenzon, L., Garofalo, A., Blandino, G., Strano, S. (2016). Cancer Gastric Chemoprevention: Isolation of Gastric Tumor-Initiating Cells. In: Strano, S. (eds) Cancer Chemoprevention. Methods in Molecular Biology, vol 1379. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3191-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3191-0_12
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3190-3
Online ISBN: 978-1-4939-3191-0
eBook Packages: Springer Protocols